Health: Novo Nordisk rivals see room to compete in $100 billion weight-loss drug market gdnonline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from gdnonline.com Daily Mail and Mail on Sunday newspapers.
NEW YORK, May 4 (Reuters) - The enormous demand for
weight-loss treatments like Novo Nordisk's Wegovy
could support as many as 10 competing products with annual sales
reaching up to $100 billion within a decade. | 12:42pm
NEW YORK (Reuters) - The enormous demand for weight-loss treatments like Novo Nordisk's Wegovy could support as many as 10 competing products with annual sales reaching up to $100 billion within a decade, mostly in the United States, industry executives and analysts said. More than half a dozen companies, from Pfizer Inc and Amgen Inc to smaller players like Altimmune Inc, are working on weight-loss therapies similar to Wegovy, viewing them as important future growth drivers. Novo was first to introduce an effective treatment shown to help people lose up to 15% of their weight. Eli Lilly and Co is expected to receive a U.S. weight loss approval for its similar drug, Mounjaro, later this year. | 06:22am
Can We Fix the Body’s Dysmetabolic State?
Copy link
By Lina Zeldovich
Copy link
WHY YOU SHOULD CARE
It s a condition that increases the risk of diabetes and more. Now hope might be around the corner.
By Lina Zeldovich
February24, 2021
An epidemic of obesity is leading to multiple diseases that share as their basis a problem called the dysmetabolic state.
This condition increases the risk of diabetes, cardiovascular disease and a serious, progressive form of nonalcoholic fatty liver disease known as nonalcoholic steatohepatitis, or NASH.
Now scientists believe they may have found a way to fight back.
It’s no secret that obesity, diabetes and heart disease are among the most devastating illnesses of the developed world. But while many health care professionals used to view them as separate, stand-alone conditions, there’s now a growing awareness that the three are tightly connected, caused by a shared problem called the dysmetabolic state, which can take hold when peop